Daniel Clow is a research professional with extensive experience in biophysics and chemical biology. Currently serving as a Research Associate in Biophysics, Assays & Screening at PROTEROS biostructures GmbH, Daniel previously worked at Wren Therapeutics Ltd, focusing on protein aggregation and fluorescent-based assays for drug screening. Prior roles include Formulation Chemist at Muc-Off and Research Scientist at G2O Water Technologies Ltd. Daniel began the career as a student at INOVYN and gained teaching experience as a self-employed English tutor. Daniel holds multiple degrees, including a Master's in Cell/Cellular and Molecular Biology from the University of Birmingham, a Master of Science in Chemical Biology and Drug Design from the University of Leeds, and a Master's in Chemistry with Research in Industry from the University of Liverpool, along with a Master of Science in Chemistry from Xi'an Jiaotong-Liverpool University.
This person is not in any offices
Wren Therapeutics
Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.